Cargando…

Treatment of Coronavirus Disease 2019 Patients with Convalescent Plasma Reveals a Signal of Significantly Decreased Mortality

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2, has spread globally, and proven treatments are limited. Transfusion of convalescent plasma collected from donors who have recovered from COVID-19 is among many approaches being studied as potentially effi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salazar, Eric, Christensen, Paul A., Graviss, Edward A., Nguyen, Duc T., Castillo, Brian, Chen, Jian, Lopez, Bevin V., Eagar, Todd N., Yi, Xin, Zhao, Picheng, Rogers, John, Shehabeldin, Ahmed, Joseph, David, Leveque, Christopher, Olsen, Randall J., Bernard, David W., Gollihar, Jimmy, Musser, James M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Investigative Pathology. Published by Elsevier Inc. 2020
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417901/ https://www.ncbi.nlm.nih.gov/pubmed/32795424 http://dx.doi.org/10.1016/j.ajpath.2020.08.001

Ejemplares similares

Significantly Decreased Mortality in a Large Cohort of Coronavirus Disease 2019 (COVID-19) Patients Transfused Early with Convalescent Plasma Containing High-Titer Anti–Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein IgG
por: Salazar, Eric, et al.
Publicado: (2021)

Treatment of Coronavirus Disease 2019 (COVID-19) Patients with Convalescent Plasma
por: Salazar, Eric, et al.
Publicado: (2020)

Limited window for donation of convalescent plasma with high live-virus neutralizing antibody titers for COVID-19 immunotherapy
por: Gontu, Abhinay, et al.
Publicado: (2021)

Relationship between Anti-Spike Protein Antibody Titers and SARS-CoV-2 In Vitro Virus Neutralization in Convalescent Plasma
por: Salazar, Eric, et al.
Publicado: (2020)

Signals of Significantly Increased Vaccine Breakthrough, Decreased Hospitalization Rates, and Less Severe Disease in Patients with Coronavirus Disease 2019 Caused by the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2 in Houston, Texas
por: Christensen, Paul A., et al.
Publicado: (2022)

Population Genomic Analysis of 1,777 Extended-Spectrum Beta-Lactamase-Producing Klebsiella pneumoniae Isolates, Houston, Texas: Unexpected Abundance of Clonal Group 307
por: Long, S. Wesley, et al.
Publicado: (2017)

Trajectory of Growth of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants in Houston, Texas, January through May 2021, Based on 12,476 Genome Sequences
por: Olsen, Randall J., et al.
Publicado: (2021)

Delta Variants of SARS-CoV-2 Cause Significantly Increased Vaccine Breakthrough COVID-19 Cases in Houston, Texas
por: Christensen, Paul A., et al.
Publicado: (2022)

Presenilin1 regulates Th1 and Th17 effector responses but is not required for experimental autoimmune encephalomyelitis
por: Cummings, Matthew, et al.
Publicado: (2018)

Immune response pattern across the asymptomatic, symptomatic and convalescent periods of COVID-19
por: Chen, Yang, et al.
Publicado: (2022)

Real-world Assessment of 2879 COVID-19 Patients Treated With Monoclonal Antibody Therapy: A Propensity Score–Matched Cohort Study
por: Cooper, Megan H, et al.
Publicado: (2021)

Sequence Analysis of 20,453 Severe Acute Respiratory Syndrome Coronavirus 2 Genomes from the Houston Metropolitan Area Identifies the Emergence and Widespread Distribution of Multiple Isolates of All Major Variants of Concern
por: Long, S. Wesley, et al.
Publicado: (2021)

How have firearm laws changed in states with unexpected decreases or increases in firearm homicide, 1990–2019?
por: Degli Esposti, Michelle, et al.
Publicado: (2023)

Convalescent Plasma Therapy for Coronavirus Disease 2019
por: Choi, Jun Yong
Publicado: (2020)

Pathology Trainee Redeployment and Education During the COVID-19 Pandemic: An Institutional Experience
por: Monroig-Bosque, Paloma del C., et al.
Publicado: (2020)

Cytokine and Chemokine Levels in Coronavirus Disease 2019 Convalescent Plasma
por: Bonny, Tania S, et al.
Publicado: (2020)

Artificially decreased dissolved oxygen increases the persistence of Trichomonas gallinae in water
por: Purple, Kathryn, et al.
Publicado: (2019)

Convalescent Plasma for Coronavirus Disease 2019: Dose is the Key
por: Yu, Jiangquan, et al.
Publicado: (2021)

Longitudinal decrease in blood oxygenation level dependent response in cerebral amyloid angiopathy
por: Switzer, Aaron R., et al.
Publicado: (2016)

A Randomized Controlled Study Assessing Convalescent Immunoglobulins vs Convalescent Plasma for Hospitalized Patients With Coronavirus 2019
por: Maor, Yasmin, et al.
Publicado: (2023)

Unbiased interrogation of memory B cells from convalescent COVID-19 patients reveals a broad antiviral humoral response targeting SARS-CoV-2 antigens beyond the spike protein
por: DiMuzio, Jillian M., et al.
Publicado: (2021)

Integrative Reverse Genetic Analysis Identifies Polymorphisms Contributing to Decreased Antimicrobial Agent Susceptibility in Streptococcus pyogenes
por: Beres, Stephen B., et al.
Publicado: (2022)

The Progress and Challenges of Convalescent Plasma Therapy for Coronavirus Disease 2019
por: Shi, Ming, et al.
Publicado: (2021)

Temporal Analysis of Serial Donations Reveals Decrease in Neutralizing Capacity and Justifies Revised Qualifying Criteria for Coronavirus Disease 2019 Convalescent Plasma
por: Girardin, Roxie C, et al.
Publicado: (2021)

Proenkephalin Decreases in Cerebrospinal Fluid with Symptom Progression of Huntington's Disease
por: Niemela, Valter, et al.
Publicado: (2020)

Guidance on the Use of Convalescent Plasma to Treat Immunocompromised Patients With Coronavirus Disease 2019
por: Bloch, Evan M, et al.
Publicado: (2023)

Convalescent Plasma for Patients With Severe Coronavirus Disease 2019 (COVID-19): A Matched Cohort Study
por: Rogers, Ralph, et al.
Publicado: (2020)

Psychological Distress and Its Correlates Among COVID-19 Survivors During Early Convalescence Across Age Groups
por: Cai, Xin, et al.
Publicado: (2020)

Convalescent Plasma: The Relay Baton in the Race for Coronavirus Disease 2019 Treatment
por: Ouyang, Jing, et al.
Publicado: (2020)

Impact of coronavirus disease 2019 on pulmonary function in early convalescence phase
por: Huang, Yiying, et al.
Publicado: (2020)

What is the optimal usage of coronavirus disease 2019 convalescent plasma donations?
por: Focosi, Daniele, et al.
Publicado: (2021)

Convalescent plasma as a treatment modality for coronavirus disease 2019 in Sudan
por: Hassan, Mozan Osman, et al.
Publicado: (2020)

Effectiveness and Controversy of Convalescent Plasma Therapy for Coronavirus Disease 2019 Patients
por: Shu, Zhanjun, et al.
Publicado: (2021)

The ability of remaining glomerular podocytes to adapt to the loss of their neighbours decreases with age
por: van der Wolde, James, et al.
Publicado: (2022)

Antibody escape and cryptic cross-domain stabilization in the SARS-CoV-2 Omicron spike protein
por: Javanmardi, Kamyab, et al.
Publicado: (2022)

Convalescents
Publicado: (1907)

Convalescence
Publicado: (1875)

Stress-level glucocorticoids increase fasting hunger and decrease cerebral blood flow in regions regulating eating
por: Bini, Jason, et al.
Publicado: (2022)

Convalescent plasma therapy: a promising coronavirus disease 2019 treatment strategy
por: Piyush, Ravikant, et al.
Publicado: (2020)

Convalescent plasma for coronavirus disease 2019 in pregnancy: a case report and review
por: Grisolia, Gianpaolo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_oq4cmv3dqtb5op1hfncs94mm2t